Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover

Nature Cell Biology

Volumn 2, Issue 9, 2000, Pages 653-660

  Henderson, Beric R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ADENOMATOUS POLYP; ANIMAL CELL; ARTICLE; CANCER RISK; COLON CANCER; COLON CARCINOGENESIS; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

3T3 CELLS; ACTIVE TRANSPORT, CELL NUCLEUS; ADENOMATOUS POLYPOSIS COLI PROTEIN; AMINO ACID SEQUENCE; ANIMAL; CARRIER PROTEINS; CELL NUCLEUS; CYTOPLASM; CYTOSKELETAL PROTEINS; HT29 CELLS; HUMAN; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; PROTEIN SORTING SIGNALS; PROTEINS; SUBCELLULAR FRACTIONS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0034282097     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35023605     Document Type: Article

References (50)

1. Miyoshi, Y. et al. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc. Natl Acad. Sci. USA 89, 4452-4456 (1992).
2. Kinzler, K.W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
3. Laken et al. Analysis of masked mutations in familial adenomatous polyposis. Proc. Natl Acad. Sci. USA 96, 2322-2326 (1999).
4. Miyoshi, Y. et al. Somatic mutations of the APC gene in colorectal tumours: mutation cluster region in the APC gene. Hum. Mol. Gen. 1, 229-233 (1992).
5. Polakis, P. The adenomatous polyposis coli (APC) tumour suppressor. Biochim. Biophys. Acta 1332, F127-F147 (1997).
6. Bienz, M. APC: The plot thickens. Curr. Opin. Genet. Dev. 9, 595-603 (1999).
7. Rubinfeld, B. et al. Association of the APC gene product with beta-catenin. Science 262, 1731-1734 (1993).
8. Su, L-K., Vogelstein B. & Kinzler, K. W. Association of the APC tumour suppressor protein with catenins. Science 262, 1734-1737 (1993).
9. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B. & Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumour suppressor protein. Proc. Natl Acad Sci. USA 92, 3046-3050 (1995).
10. Gumbiner, B.M. Carcinogenesis: A balance between β-catenin and APC. Curr. Biol. 7, R443-R446 (1997).
11. Morin, P. J. β-catenin signaling and cancer. BioEssays 21, 1021-1030 (1999).
12. Peifer, M. & Polakis, P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287, 1606-1609 (2000).
13. Morin, P. J. et al. Activation of β-catenin-TCF signalling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790 (1997).
14. Rubinfeld, B. et al. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275, 1790-1792 (1997).
15. Satoh, S. et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nature Genet. 24, 245-250 (2000).
16. He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 (1998).
17. Aoki, M., Hecht, A., Kruse, U., Kemler, R. & Vogt, P. K. Nuclear endpoint of Wnt signalling: Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc. Natl Acad. Sci. USA 96, 139-144 (1999).
18. Tetsu, O. & McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426 (1999).
19. Smith, K. J., Levy, D. B., Maupin, P., Pollard, T. D., Vogelstein, B. & Kinzler, K. W. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res. 54, 3672-3675 (1994).
20. Munemitsu, S., Souza, B., Muller, O., Albert, I., Rubinfeld, B. & Polakis, P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res. 54, 3676-3681 (1994).
21. Mimori-Kiyosue, Y, Shiina, N. & Tsukita, S. Adenomatous Polyposis Coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells. J. Cell Biol. 148, 505-517 (2000).
22. Neufeld, K. L. & White, R. L. Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. Proc. Natl Acad. Sci. USA 94, 3034-3039 (1997).
23. Efstathiou, J. A. et al. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc. Natl Acad. Sci. USA 95, 3122-3127 (1998).
24. Deka, J. et al. The APC protein binds to A/T rich DNA sequences. Oncogene 18, 5654-5661 (1999).
25. Miyashiro, I. et al. Subcellular localization of the APC protein: immunoelectron microscopic study of the association of the APC protein with catenin. Oncogene 11, 89-96 (1995).
26. Fornerod, M., Ohno, M., Yoshida, M. & Mattaj, I. W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051-1060 (1997).
27. Stade, K., Ford, C. S., Guthrie, C. & Weis, K. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90, 1041-1050 (1997).
28. Neville, M., Stutz, F., Lee, L., Davis, L. I. & Rosbash, M. The importin-beta family member CRM1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 7, 767-775 (1997).
29. Ossareh-Nazari, B., Bachelerie, F. & Dargemont, C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278, 141-144 (1997).
30. Fukuda, M. et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390, 308-311 (1997).
31. Gorlich, D. Transport into and out of the cell nucleus. EMBO J. 17, 2721-2727 (1998).
32. Henderson, B. R. and Eleftheriou, A. A comparison of the activity, sequence specificity and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 256, 213-224 (2000).
33. Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T. & Levine, A. J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554-564 (1998).
34. Bogerd, H. P., Fridell, R. A., Benson, R. E., Hua, J. & Cullen, B. R. Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol. Cell. Biol. 16, 4207-4214 (1996).
35. Kudo, N. et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to Crm1. Exp. Cell Res. 242, 540-547 (1998).
36. Nakagawa, H. et al. Identification of a brain-specific APC homologue, APCL, and its interaction with β-catenin. Cancer Res. 58, 5176-5181 (1998).
37. van Es, J.H. et al. Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. Curr. Biol. 9, 105-108 (1999).
38. Joslyn, G., Richardson, D. S., White, R. & Alber, T. Dimer formation by an N-terminal coiled coil in the APC protein. Proc. Natl. Acad. Sci. USA 90, 11109-11113 (1993).
39. Su, L-K. et al. Association between wild-type and mutant APC gene products. Cancer Res. 53, 2728-2731 (1993).
40. Groden, J. et al. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumour suppressor gene. Cancer Res. 55, 1531-1539 (1995).
41. Nishisho, I. et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253, 665-669 (1991).
42. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B. & Polakis, P. Downregulation of β-catenin by human Axin and its association with the APC tumour suppressor, β-catenin and GSK3β. Curr. Biol. 8, 573-581 (1998).
43. Su, L-K. et al. APC binds to the novel protein EB1. Cancer Res. 55, 2972-2977 (1995).
44. Matsumine, A. et al. Binding of APC to the human homolog of the Drosophila Discs Large tumour suppressor protein. Science 272, 1020-1023 (1996).
45. Hatashi, S. et al. A Drosophila homolog of the tumour suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo. Proc. Natl. Acad. Sci. USA 94, 242-247 (1997).
46. ctn Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression. Proc. Natl. Acad. Sci. USA 96, 7980-7985 (1999).
47. Simcha, I. et al. Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin. J. Cell Biol. 141, 1433-1448 (1998).
48. Fagotto, F., Gluck, U. & Gumbiner, B. M. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin. Curr. Biol. 8, 181-190 (1998).
49. Yokoya, F., Imamoto, N., Tachibana, T. & Yoneda, Y. β-catenin can be transported into the nucleus in a Ran-unassisted manner. Mol. Biol. Cell 10, 1119-1131 (1999).
50. Prieve, M.G. & Waterman, M.L. Nuclear localization and formation of β-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression. Mol. Cell. Biol. 19, 4503-4515 (1999).